Stock News

Cvs Health (CVS) Holder Northeast Investment Management Trimmed Position; Adobe Systems (ADBE) Valuation Rose While Suncoast Equity Management Boosted Its Position

CVS Health Corporation (NYSE:CVS) Logo

Northeast Investment Management decreased its stake in Cvs Health Corp (CVS) by 1.72% based on its latest 2017Q4 regulatory filing with the SEC. Northeast Investment Management sold 5,028 shares as the company’s stock declined 17.45% with the market. The institutional investor held 287,431 shares of the medical and nursing services company at the end of 2017Q4, valued at $20.84M, down from 292,459 at the end of the previous reported quarter. Northeast Investment Management who had been investing in Cvs Health Corp for a number of months, seems to be less bullish one the $67.07B market cap company. The stock increased 0.20% or $0.13 during the last trading session, reaching $65.97. About 1.16M shares traded. CVS Health Corporation (NYSE:CVS) has declined 22.81% since May 16, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

Suncoast Equity Management increased its stake in Adobe Systems (ADBE) by 53.77% based on its latest 2017Q4 regulatory filing with the SEC. Suncoast Equity Management bought 24,585 shares as the company’s stock rose 22.17% while stock markets declined. The institutional investor held 70,310 shares of the prepackaged software company at the end of 2017Q4, valued at $12.32 million, up from 45,725 at the end of the previous reported quarter. Suncoast Equity Management who had been investing in Adobe Systems for a number of months, seems to be bullish on the $116.45B market cap company. The stock decreased 0.06% or $0.144 during the last trading session, reaching $236.456. About 541,322 shares traded. Adobe Systems Incorporated (NASDAQ:ADBE) has risen 66.71% since May 16, 2017 and is uptrending. It has outperformed by 55.16% the S&P500.

More notable recent Adobe Systems Incorporated (NASDAQ:ADBE) news were published by: Nasdaq.com which released: “Don’t Let Adobe (ADBE) Stock Slip Through Your Fingers” on May 10, 2018, also Seekingalpha.com with their article: “DocuSign raises IPO price range” published on April 25, 2018, Streetinsider.com published: “JANA Shows New Stakes in Apple (AAPL), Boston Scientific (BSX), Dropbox (DBX), iQIYI (IQ) (more..) -13F” on May 15, 2018. More interesting news about Adobe Systems Incorporated (NASDAQ:ADBE) were released by: Streetinsider.com and their article: “Lone Pine’s 13F Shows New Stake in Dollar Tree (DLTR), Square (SQ), T-Mobile (TMUS) (more…)” published on May 15, 2018 as well as Streetinsider.com‘s news article titled: “Loeb’s Third Point LLC Enters Adobe (ADBE), EA (EA), Wynn (WYN) (more…) – 13F” with publication date: May 15, 2018.

Suncoast Equity Management, which manages about $229.33M and $362.34 million US Long portfolio, decreased its stake in Accenture Ltd (NYSE:ACN) by 4,358 shares to 194,470 shares, valued at $29.77M in 2017Q4, according to the filing. It also reduced its holding in Alphabet Cl A by 447 shares in the quarter, leaving it with 6,576 shares, and cut its stake in Lowes (NYSE:LOW).

Since December 13, 2017, it had 1 insider purchase, and 16 sales for $87.08 million activity. Shares for $3.63M were sold by Rencher Bradley. The insider GARRETT MARK sold $10.21 million. $5.97 million worth of Adobe Systems Incorporated (NASDAQ:ADBE) was sold by LAMKIN BRYAN on Wednesday, January 31. Morris Donna sold $5.81 million worth of stock. Lewnes Ann sold $338,846 worth of Adobe Systems Incorporated (NASDAQ:ADBE) on Wednesday, December 13. NARAYEN SHANTANU sold $32.66M worth of stock.

Investors sentiment decreased to 0.89 in 2017 Q4. Its down 0.22, from 1.11 in 2017Q3. It dived, as 47 investors sold ADBE shares while 389 reduced holdings. 107 funds opened positions while 280 raised stakes. 410.42 million shares or 1.09% less from 414.95 million shares in 2017Q3 were reported. Grantham Mayo Van Otterloo Ltd Liability stated it has 0.04% in Adobe Systems Incorporated (NASDAQ:ADBE). Lazard Asset Mngmt invested 0.1% of its portfolio in Adobe Systems Incorporated (NASDAQ:ADBE). Violich Mngmt owns 2,925 shares. Calamos Advisors Ltd Liability reported 55,290 shares. Robeco Institutional Asset Mngmt Bv invested in 208,890 shares. California State Teachers Retirement System reported 817,456 shares stake. Shamrock Asset Mngmt Llc stated it has 0.02% in Adobe Systems Incorporated (NASDAQ:ADBE). 42,214 were reported by Kdi Capital Ptnrs Ltd Liability. Bnp Paribas Asset Management Holding Sa holds 0.2% or 136,584 shares. Cim Ltd Liability Com has invested 0.2% in Adobe Systems Incorporated (NASDAQ:ADBE). Pointstate Capital Lp holds 0.08% or 48,288 shares in its portfolio. Assetmark stated it has 1,257 shares or 0% of all its holdings. First Commercial Bank Of Hutchinson has invested 0.41% of its portfolio in Adobe Systems Incorporated (NASDAQ:ADBE). Kentucky Retirement stated it has 30,398 shares. Blume Capital Mngmt Incorporated has invested 0.03% in Adobe Systems Incorporated (NASDAQ:ADBE).

Among 39 analysts covering Adobe Systems (NASDAQ:ADBE), 28 have Buy rating, 0 Sell and 11 Hold. Therefore 72% are positive. Adobe Systems had 157 analyst reports since August 11, 2015 according to SRatingsIntel. Jefferies maintained the stock with “Buy” rating in Wednesday, September 20 report. RBC Capital Markets maintained it with “Buy” rating and $179.0 target in Friday, December 8 report. The firm has “Mkt Perform” rating given on Friday, December 11 by FBR Capital. The company was maintained on Tuesday, August 22 by Canaccord Genuity. Credit Suisse maintained Adobe Systems Incorporated (NASDAQ:ADBE) rating on Wednesday, January 6. Credit Suisse has “Neutral” rating and $70 target. Robert W. Baird upgraded it to “Neutral” rating and $85.0 target in Tuesday, August 25 report. The company was downgraded on Tuesday, December 12 by J.P. Morgan. Credit Suisse reinitiated Adobe Systems Incorporated (NASDAQ:ADBE) rating on Thursday, April 21. Credit Suisse has “Neutral” rating and $105 target. Cowen & Co maintained the shares of ADBE in report on Wednesday, September 21 with “Outperform” rating. The rating was maintained by RBC Capital Markets on Wednesday, February 8 with “Outperform”.

Northeast Investment Management, which manages about $1.26 billion and $1.19B US Long portfolio, upped its stake in Vanguard Ftse Emerging Markets (VWO) by 15,145 shares to 314,446 shares, valued at $14.44 million in 2017Q4, according to the filing. It also increased its holding in Celgene Corp (NASDAQ:CELG) by 13,941 shares in the quarter, for a total of 146,698 shares, and has risen its stake in Vanguard Short Term Corp Bond (VCSH).

Investors sentiment decreased to 0.72 in 2017 Q4. Its down 0.16, from 0.88 in 2017Q3. It turned negative, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. Marshall Wace Llp has invested 0.01% of its portfolio in CVS Health Corporation (NYSE:CVS). Greenwood Cap Ltd Limited Liability Company reported 25,972 shares. Adirondack Tru stated it has 9,538 shares or 0.5% of all its holdings. Stone Ridge Asset Ltd Liability Com owns 99,178 shares. Oppenheimer Asset Mngmt invested in 0.05% or 25,367 shares. Parnassus Invs Ca reported 7.21 million shares stake. Smithbridge Asset Mgmt Inc De owns 15,380 shares or 0.7% of their US portfolio. Mengis Capital reported 0.49% in CVS Health Corporation (NYSE:CVS). Federated Investors Pa owns 472,956 shares. Washington Com owns 216,023 shares. Clark Estates owns 4.22% invested in CVS Health Corporation (NYSE:CVS) for 352,781 shares. 2,910 are held by Teewinot Cap Advisers Limited Liability. Swedbank has invested 0.86% in CVS Health Corporation (NYSE:CVS). Btc has 1.07% invested in CVS Health Corporation (NYSE:CVS). Godshalk Welsh Mngmt holds 3,705 shares or 0.27% of its portfolio.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on August, 14. They expect $1.61 EPS, up 21.05% or $0.28 from last year’s $1.33 per share. CVS’s profit will be $1.64B for 10.24 P/E if the $1.61 EPS becomes a reality. After $1.48 actual EPS reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 8.78% EPS growth.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: 247Wallst.com which released: “Alibaba, CVS, Tesla and Other Earnings to Watch For This Week” on April 29, 2018, also Seekingalpha.com with their article: “Trade Mistake 3: CVS Boredom Trade” published on May 09, 2018, Nasdaq.com published: “3 Top Stocks With High Dividend Yields” on May 15, 2018. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Prnewswire.com and their article: “Increasing Health-conscious and Sports Vision Treatments Impacting HealthCare Sector” published on May 16, 2018 as well as Streetinsider.com‘s news article titled: “Glenview Capital Enters AmerisourceBergen (ABC), Express Scripts (ESRX), T-Mobile (TMUS) (more…) -13F” with publication date: May 15, 2018.

Since February 16, 2018, it had 2 insider purchases, and 1 sale for $713,454 activity. 24,300 shares valued at $1.51M were bought by DORMAN DAVID W on Friday, May 4. 10,000 CVS Health Corporation (NYSE:CVS) shares with value of $619,900 were bought by BROWN C DAVID II.

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 77 analyst reports since July 22, 2015 according to SRatingsIntel. The company was maintained on Wednesday, May 2 by Oppenheimer. RBC Capital Markets maintained it with “Outperform” rating and $132 target in Wednesday, August 5 report. The rating was initiated by UBS on Thursday, October 6 with “Buy”. JP Morgan maintained CVS Health Corporation (NYSE:CVS) rating on Monday, November 2. JP Morgan has “Overweight” rating and $123 target. The firm earned “Hold” rating on Friday, October 27 by Robert W. Baird. The stock of CVS Health Corporation (NYSE:CVS) has “Buy” rating given on Tuesday, January 2 by Needham. Argus Research maintained CVS Health Corporation (NYSE:CVS) rating on Monday, August 10. Argus Research has “Buy” rating and $118.0 target. The firm has “Buy” rating given on Monday, December 4 by Needham. The firm has “Neutral” rating given on Friday, November 3 by Citigroup. The firm has “Buy” rating by SunTrust given on Friday, October 13.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *